EMMA-CSNCT07751887
Middle Meningeal Artery Embolisation in Chronic Subdural Hematoma
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Enrollment reopened
- Trial sites expanded: 1 → 6 locations
- Notable Eligibility criteria expanded, about 8 words
- Secondary endpoints: details revised at 1 of 1 entry
- Publications: details revised at 5 of 5 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (1)
Arms and interventions
Patients with chronic subdural hematoma (cSDH) who undergo middle meningeal artery embolization (MMAE). This procedure is performed either as a standalone treatment or as an adjunct to surgical evacuation, based on clinical indication.
Patients with chronic subdural hematoma (cSDH) who receive standard clinical care without undergoing middle meningeal artery embolization. This includes standard surgical evacuation (burr-hole craniostomy) or conservative management (observation, medication) based on current guidelines.
Devices: Middle Meningeal Artery Embolisation
Sites
6 sites in 1 country